SCHEDULE 13G

Company

Aclaris Therapeutics, Inc.

Filed

October 27, 2020

Accession Number

0001104659-20-118249

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →